You are now visiting tipharma.com.
On 1 January, 2016, TI Pharma and CTMM merged
to form a new organization called Lygature.
Please note that information on the tipharma.com site has not
been updated since, and is retained as an archive.
For up-to-date information, please visit lygature.org.
Since 2013, TI Pharma has embarked on a new phase as an independent non-profit that enables international partnership in drug discovery and development.
Most of the projects funded by the government’s gas reserve fund (“FES”) have been completed (in alphabetical order):
“What TI Pharma can deliver from collaborations is more efficient healthcare, faster time to market and quicker patient benefit.”